'Cancer Patients Better Life Experience'

NCT05827289 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2023-07-06

No results posted yet for this study

Summary

The purpose of this study is to compare health-related quality of life, specifically fatigue, in melanoma patients treated with immunotherapy who use or do not use a patient-centered mobile coaching and monitoring system (CAPABLE). It is expected that by using the CAPABLE eHealth tool, patients' fatigue worsens less significantly (10 points) in the first 3 months follow-up than observed in usual care.

Conditions

Interventions

DEVICE

Cancer Patients Better Life Experience (CAPABLE)

The CAPABLE system serves three main goals for the patient: symptom monitoring, information needs fulfilment and interventions to improve mental- and physical wellbeing. These are available to the patient as a smartphone application that is connected to a smartwatch to monitor activity, blood pressure, sleep and heart rate. Patients are able to report symptoms experienced from the treatment and are eligible to do interventions such as mindfulness or yoga. Patients will receive the CAPABLE application and smartwatch for a minimum 3 to a maximum of 6 months after start treatment.

Sponsors & Collaborators

  • University of Pavia

    collaborator OTHER
  • University of Haifa

    collaborator OTHER
  • Biomeris s.r.l.

    collaborator UNKNOWN
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • IBM Research

    collaborator UNKNOWN
  • Bitsens JSC

    collaborator UNKNOWN
  • Poznań University of Technology

    collaborator UNKNOWN
  • Instituti Clinici Scientifici Maugeri

    collaborator UNKNOWN
  • Deontics LTD

    collaborator UNKNOWN
  • Associazione Italiana Malati di Cancro

    collaborator UNKNOWN
  • Universidad Politecnica de Madrid

    collaborator OTHER
  • The Netherlands Cancer Institute

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-15
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827289 on ClinicalTrials.gov